|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01889 SANAI HEALTH GP
Nominal 
0.340 -0.020 (-5.556%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 85,217 | 122,098 | 175,923 | 67,608 |
| Cost of Sales | -- | -- | (68,353) | (86,913) | (84,248) | (27,053) |
| Gross Profit | -- | -- | 16,864 | 35,185 | 91,675 | 40,555 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | 2,517 | 341 | -- | |
| Profit / (Loss) on Disposal | -- | -- | (124) | -- | (2,484) | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | (456) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | -- | -- | (12,939) | 22,364 | 55,771 | 25,500 | |
| Taxation | -- | -- | (968) | (8,997) | (20,574) | (8,625) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | 17,308 | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 1,491 | 5,266 | (5,980) | (7,850) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (22,040) | -- | 4,892 | 18,633 | 29,217 | 9,025 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | 1,630 | 1,607 | 1,713 | (712) |
| Depreciation & Amortisation | -- | -- | 2,787 | 4,062 | 3,524 | 3,547 |
| Directors' Emoluments | -- | -- | 2,324 | 1,881 | 5,572 | 1,382 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Qualified | Qualified | Qualified | Qualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -14.410 | -- | 3.370 | 14.520 | 23.750 | 7.250 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.081 | 2.499 | (0.458) | (0.013) |
| NBV per share ($) | -- | -- | 2.106 | 2.059 | 1.921 | 1.622567 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -22,040 |
| %Change | -- |
| EPS / (LPS) | RMB -0.144 |
| NBV Per Share (¥) | RMB -- |